Skip to Content


Agency Information Collection Activities: Submission for OMB Review; Comment Request

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a list of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (301) 443-7978.

Opioid Drugs in Maintenance and Detoxification Treatment of Opioid Dependence

42 CFR Part 8 (OMB No. 0930-0206, Revision)—This regulation establishes a certification program managed by SAMHSA's Center for Substance Abuse Treatment (CSAT). The regulation requires that Opioid Treatment Programs (OTPs) be certified. “Certification” is the process by which SAMHSA determines that an OTP is qualified to provide opioid treatment under the Federal opioid treatment standards established by the Secretary of Health and Human Services. To become certified, an OTP must be accredited by a SAMHSA-approved accreditation body. The regulation also provides standards for such services as individualized treatment planning, increased medical supervision, and assessment of patient outcomes. This submission seeks continued approval of the information collection requirements in the regulation, minor changes to Form SMA-162, and approval of a new form to be used in implementing the regulation. Start Printed Page 49366

SAMHSA currently has approval for the Application for Certification to Use Opioid Drugs in a Treatment Program Under 42 CFR 8.11 (Form SMA-162) and the Application for Approval as Accreditation Body Under 42 CFR 8.3(b) (Form SMA-163). SAMHSA also is seeking approval of a new form that has been developed at the request of the treatment field, the Exception Request and Record of Justification Under 42 CFR 8.12 (Form SMA-168), which may be used on a voluntary basis by physicians when there is a patient care situation in which the physician must make a treatment decision that differs from the treatment regimen required by the regulation. This is a simplified, standardized form to facilitate the documentation, request, and approval process for exceptions. The tables that follow summarize the annual reporting burden associated with the regulation, including burden associated with the forms.

Estimated Annual Reporting Requirement Burden for Accreditation Bodies

42 CFR citationPurposeNo. of respondentsResponses/respondentsHours/ responseTotal hours
8.3 (b)(1-11)Initial approval (SMA-163)213.06.0
8.3 (c)Renewal of approval (SMA-163)211.02.0
8.3 (e)Relinquishment notification110.50.5
8.3 (f)(2)Non-renewal notification to accredited OTP's1900.19.0
8.4(d)(2) (b)(1)(ii)Notification to SAMHSA for seriously noncompliant programs221.04.0
8.4 (b)(1)(iii)Notification to OTP for serious noncompliance221.04.0
8.4 (d)(1)General documents and information to SAMHSA upon request740.514.0
8.4(d)(2)Accreditation survey to SAMHSA upon request7530.027.42
8.4 (b)(3)List of surveys, surveyors to SAMHSA upon request760.28.4
8.4 (d)(4)Report of less than full accreditation to SAMHSA72.50.58.75
8.4 (d)(5)Summaries of Inspections7500.5175.0
8.4(e)Notifications of Complaints750.517.5
8.6(a)(2) and (b)(3)Revocation notification and to Accredited OTP's1500.315.0
8.6(b)Submission of 90-day Corrective plan to SAMHSA111010.0
8.6(b)(1)Notification to accredited OTP's of Probationary Status1500.315.0

Estimated Annual Reporting Requirement Burden for Opioid Treatment Programs

42 CFR citationPurposeNo. of respondentsResponses/respondentsHours/ responseTotal hours
8.11(b)New programs approval (SMA-162)7511.50112.50
8.11(b)Renewal of approval (SMA-162)35011.00350.00
8.11(b)Relocation of Program (SMA-162)3511.1740.95
8.11(d)Application for transitional certification (SMA-162)*711.5811.06
8.11(e)(1)Application for provisional certification751175.00
8.11(e)(2)Application for extension of provisional certification301.257.50
8.11(f)(5)Notification of sponsor or medical director change (SMA-162)601.212.00
8.11(g)(2)Documentation to SAMHSA for interim maintenance1111.00
8.11(h)Request to SAMHSA for Exemption from 8.11 and 8.12 (SMA-168)1,1006.1521003.2
8.11(i)(1)Notification to SAMHSA Before Establishing Medication Units (SMA-162)101.252.5
8.12(j)(2)Notification to State Health Officer When Patient Begins Interim Maintenance120.336.6
8.24Contents of Appellant Request for Review of Suspension21.25.50
8.25(a)Informal Review Request211.002.00
8.26(a)Appellant's Review File and Written Statement215.0010.00
8.28(a)Appellant's Request for Expedited Review211.002.00
8.28(c)Appellant Review File and Written Statement215.0010.00
* This is a one-time requirement that will be fully met during the first three years of approval for the final rule.

SAMHSA believes that the recordkeeping requirements in the regulation are customary and usual practices within the medical and rehabilitative communities and has not calculated a response burden for them. The recordkeeping requirements set forth in 42 CFR 8.4, 8.11 and 8.12 include maintenance of the following: 5-year retention by accreditation bodies of certain records pertaining to accreditation; documentation by an OTP of the following: A patient's medical examination when admitted to treatment, a patient's history, a treatment plan, any prenatal support provided the patient, justification of unusually large initial doses, changes in a patient's dosage schedule, justification of unusually large daily doses, the rationale for decreasing a patient's clinic Start Printed Page 49367attendance, and documentation of physiologic dependence.

The rule also includes requirements that OTPs and accreditation organizations disclose information. For example, 42 CFR 8.12(e)(1) requires that a physician explain the facts concerning the use of opioid drug treatment to each patient. This type of disclosure is considered to be consistent with the common medical practice and is not considered an additional burden. Further, the rule requires, under § 8.4(i)(1) that accreditation organizations shall make public their fee structure; this type of disclosure is standard business practice and is not considered a burden.

Written comments and recommendations concerning the proposed information collection should be sent within 30 days of this notice to: Allison Herron Eydt, Human Resources and Housing Branch, Office of Management and Budget, New Executive Office Building, Room 10235, Washington, DC 20503.

Start Signature

Dated: July 23, 2002.

Richard Kopanda,

Executive Officer, SAMHSA.

End Signature End Preamble

[FR Doc. 02-19167 Filed 7-29-02; 8:45 am]